 |
|
News & Events > Press ReleasesOrSense NBM-200 Non-Invasive Hemoglobin Device Implemented by Children's Hospital Los AngelesSep. 3, 2019OrSense NBM-200 Non-Invasive Hemoglobin Device Selected by the Central Blood Bank of CataloniaJul. 11, 2019OrSense delivers first systems in MexicoOct. 28, 2014Haema AG replaces capillary testing with OrSense NBM200 Non-invasive Hemoglobin testing deviceMay. 31, 2014OrSense Non Invasive Hemoglobin Monitor Received CFDA Approval for Marketing in ChinaOct. 28, 2013- The device will be launched at the China International Medical Equipment Fair - OrSense Non Invasive Hemoglobin Monitor Shown Safe and Accurate for Pre-Donation Screening in Blood BanksMay. 28, 2013Four abstracts demonstrating the clinical value of NBM-200 to be presented at the ISBT in Amsterdam OrSense moves its headquarters to Petah-Tikva, Israel as of October 25, 2012Oct. 24, 2012OrSense moves its headquarters to Petah-Tikva, Israel as of October 25, 2012 OrSense Non Invasive Hemoglobin Monitor Gains Worldwide Recognition as a Safe, Accurate, and User Friendly SolutionOct. 3, 2012A body of publications, five of which at the AABB Annual Meeting, highlights the clinical value of OrSenses system; Glasswing, next-generation, wireless, non-invasive hemoglobin measurement system for anemia screening, to be launched at AABB OrSense Introduces Glasswing, its Next-Generation, Wireless, Non-Invasive Hemoglobin Monitoring System for Anemia ScreeningJul. 8, 2012Launched today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico OrSense's non invasive Hemoglobin Monitor Accurately Detects Anemia and Hemorrhage During Pregnancy and DeliveryJun. 13, 2012Results showing accurate performance of device presented at the European Congress for Perinatal Medicine (ECPM) - OrSense's Non-Invasive Hemoglobin Measurement System for Pre-Donation Screening of Anemia Delivers Superior Clinical Value Compared to Current MethodsOct. 19, 2011Representatives of three hospitals and Red Cross blood donation centers will present data on OrSense's non-invasive hemoglobin screening system at AABB OrSense's Non-Invasive Hemoglobin Monitor Offers for the First Time the Ability to Detect Hemorrhage Accurately and Within MinutesOct. 15, 2011The non-invasive monitor can prevent unnecessary deaths from post-partum hemorrhage and other acute bleeding situations - Data introduced in an oral presentation at the American Society of Anesthesiologists Meeting OrSense's Non Invasive Hemoglobin Monitor has the Potential to Enhance Recruitment of Blood DonorsJun. 18, 2011In a statement on the World Blood Donors Day, Dr. Emma Castro, CEO of the Transfusion Center of the Spanish Red Cross in Madrid, stated, "Our donors are very excited about the implementation of the new OrSense system, and we are looking at it as a tool that will contribute to enlarge our blood donor community." Dr. Castro and others will be presenting data showing that OrSense`s non-invasive hemoglobin monitor can be safely and accurately used for assessing hemoglobin levels, anemia and hemorrhage. |
Press Releases Archive |